Design of the PID Evaluation and Clinical Health (PEACH) Study

Area of Science:

• Reproductive Health
• Infectious Diseases
• Clinical Trials

Background:

• Pelvic inflammatory disease (PID) is a common infection in women.
• Current treatment strategies include inpatient and outpatient antimicrobial regimens.
• The optimal treatment approach for PID requires further evaluation.

Purpose of the Study:

• To compare the effectiveness and cost-effectiveness of inpatient versus outpatient antimicrobial treatment for PID.
• To assess the impact of PID treatment on long-term health outcomes, including infertility, ectopic pregnancy, and chronic pelvic pain.
• To provide evidence-based guidance for selecting between inpatient and outpatient antibiotic therapy for PID.

Main Methods:

• A multicenter, randomized clinical trial (PEACH study) involving women with PID.
• Comparison of currently recommended antibiotic combinations for PID.
• Collection of data on patient selection, treatment adherence, follow-up, quality of life, and health outcomes.
• Statistical analyses to determine treatment effectiveness and cost-effectiveness.

Main Results:

• The PEACH study is the largest prospective study of PID in North America.
• Enrollment included 312 women in the first 11 months, with 59% consent rate.
• High follow-up rate (95%) achieved after a median of 5.5 months.

Conclusions:

• The PEACH study provides a rationale for choosing between inpatient and outpatient antibiotic treatment for PID.
• Findings will inform clinical decision-making for PID management.
• The study contributes significant data to the understanding of PID treatment outcomes.